QTEX · QTREX Quantum Ltd.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-14 | Chappel-Ram Shlomit |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-07-06 | shabtay abraham |
COO and VP of R&D |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event. |
Ordinary Shares
|
550,000 |
| 2026-07-06 | Rozanovich Yoav |
Chief Business Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on October 1, 2026, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event. |
Ordinary Shares
|
550,000 |
| 2026-07-06 | Yechezkely Hayon Daniella |
Chief Technology Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event. |
Ordinary Shares
|
550,000 |
| 2026-07-06 | Tehila Yafit |
Chief Financial Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event. |
Ordinary Shares
|
550,000 |
| 2026-06-01 | Tehila Yafit |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying Ordinary Shares received were then sold. The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan. |
Ordinary Shares
|
28,100 |
| 2026-05-29 | Yechezkely Hayon Daniella |
Chief Technology Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying Ordinary Shares received were then sold. |
Ordinary Shares
|
50,000 |
| 2026-05-29 | shabtay abraham |
COO and VP of R&D |
Convert↓
Filing footnotes — Employee share options (right to buy) (Direct)
The options were granted with an exercise price of NIS 0.37. The options were granted on November 1, 2020 and are fully vested as of June 1, 2022. |
Employee share options (right to buy)
|
38,095 |
| 2026-05-29 | shabtay abraham |
COO and VP of R&D |
Convert↑
|
Ordinary Shares
|
95,239 |
| 2026-05-29 | shabtay abraham |
COO and VP of R&D |
Convert↓
Filing footnotes — Employee share options (right to buy) (Direct)
The options were granted with an exercise price of AUD 0.37. The options were granted on February 15, 2020 and became fully vested as of June 2, 2019. |
Employee share options (right to buy)
|
57,144 |
| 2026-05-29 | Tehila Yafit |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
Following the vesting of the Restricted Share Units ("RSUs") granted under Qtrex Quantum Ltd.'s Insense Medical 2019 Plan, with each RSU representing the right to receive, following vesting, one ordinary share, no par valuer per share (the "Ordinary Shares"), the underlying Ordinary Shares received were then sold. The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan. |
Ordinary Shares
|
1,900 |
| 2026-05-28 | Tehila Yafit |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan. |
Ordinary Shares
|
15,000 |
| 2026-05-28 | Tehila Yafit |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan. |
Ordinary Shares
|
15,000 |
| 2026-05-28 | Tehila Yafit |
Chief Financial Officer |
Convert↓
Filing footnotes — Employee share options (right to buy) (Direct)
The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan. The options were granted on February 21, 2021 and became fully vested as of February 23, 2024. |
Employee share options (right to buy)
|
13,605 |
| 2026-05-27 | Tehila Yafit |
Chief Financial Officer |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan. |
Ordinary Shares
|
13,605 |
| 2026-05-27 | Tehila Yafit |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan. |
Ordinary Shares
|
13,605 |
| 2026-05-27 | Tehila Yafit |
Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan. |
Ordinary Shares
|
16,395 |
| 2026-04-13 | Rozanovich Yoav |
Chief Business Officer |
Other↑
|
No Securities Owned
|
0 |